News

The Committee for Medicinal Products for Human Use’s (CHMP) positive opinion is now referred for final action to the European Commission. Subject to approval by the European Commission,

The recommendation by the Committee for Medicinal Products for Human Use (CHMP) is based on results from the first randomized placebo-controlled trial of a biologic treatment in children

The company sold one million shares of common stock at $1.10 per share. The investors also received warrants to purchase an additional 150,000 shares of common stock at

The new company will be named Life Technologies Corporation and will be traded on the NASDAQ global select market under the ticker symbol ‘LIFE’ beginning November 24, 2008.

Dr Svensson is currently the director of the Center for Aortic Surgery and director of the Marfan syndrome and Connective Tissue Disorder Clinic in the department of thoracic

As under the previous agreement, Toshiba will offer Vital Images’s solution through its subsidiaries and distributors in more than 50 nations in North and South America, Europe, the

This acquisition brings in-house critical core competencies – the development of 3D volume rendering and advanced visualization capabilities for all Toshiba modalities. Toshiba is patterning this acquisition after

As previously announced, the financing was led by TVM Capital and included participation from new investors Mizuho Capital, Morningside Group and Japan Asia Investment Co. Existing Argos investors

Mr Smith will report to Richard Friedman, BioScrip’s chairman and CEO, and will begin work on or before January 2, 2009, after a short transition period with his